Tong Yang

Tianjin, 300211, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

ATP6V0B promotes the tumorigenesis of bladder cancer by activating PAQR4/PI3K/AKT signaling.

ATP6V0B promotes the tumorigenesis of bladder cancer by activating PAQR4/PI3K/AKT signaling.

Journal: BMC cancer

Published: December 29, 2024

Elevated Expression of NOP16 as a Novel Prognostic Biomarker of Prostate Cancer.

Elevated Expression of NOP16 as a Novel Prognostic Biomarker of Prostate Cancer.

Journal: Annals of clinical and laboratory science

Published: August 25, 2023

LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signaling.

LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signaling.

Journal: Toxicology letters

Published: February 22, 2021

Silver nanoparticles regulate autophagy through lysosome injury and cell hypoxia in prostate cancer cells.

Silver nanoparticles regulate autophagy through lysosome injury and cell hypoxia in prostate cancer cells.

Journal: Journal of biochemical and molecular toxicology

Published: July 17, 2019

Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress.

Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress.

Journal: Carcinogenesis

Published: March 13, 2019

Metformin prevents nephrolithiasis formation by inhibiting the expression of OPN and MCP-1 in vitro and in vivo.

Metformin prevents nephrolithiasis formation by inhibiting the expression of OPN and MCP-1 in vitro and in vivo.

Journal: International journal of molecular medicine

Published: August 01, 2018

Overexpression levels of cripto-1 predict poor prognosis in patients with prostate cancer following radical prostatectomy.

Overexpression levels of cripto-1 predict poor prognosis in patients with prostate cancer following radical prostatectomy.

Journal: Oncology letters

Published: July 26, 2018

hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.

hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.

Journal: The Prostate

Published: June 15, 2018

Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress.

Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress.

Journal: Carcinogenesis

Published: April 20, 2018

Metformin Prevents Renal Stone Formation through an Antioxidant Mechanism In Vitro and In Vivo.

Metformin Prevents Renal Stone Formation through an Antioxidant Mechanism In Vitro and In Vivo.

Journal: Oxidative medicine and cellular longevity

Published: February 11, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026